リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Time course of serum cytokine level changes within 72 h after onset in children with acute encephalopathy and febrile seizures」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Time course of serum cytokine level changes within 72 h after onset in children with acute encephalopathy and febrile seizures

Tomioka, Kazumi Nishiyama, Masahiro Tokumoto, Shoichi Yamaguchi, Hiroshi Aoki, Kazunori Seino, Yusuke Toyoshima, Daisaku Kurosawa, Hiroshi Tada, Hiroko Sakuma, Hiroshi Nozu, Kandai Maruyama, Azusa Tanaka, Ryojiro Iijima, Kazumoto Nagase, Hiroaki 神戸大学

2023.01.07

概要

Background
Cytokine levels have been measured in acute encephalopathy (AE) to determine its pathology or as a diagnostic biomarker to distinguish it from febrile seizures (FS); however, the dynamics of cytokine level changes have not yet been fully captured in these two neurological manifestations. Thus, we aimed to explore the time course of serum cytokine level changes within 72 h after onset in AE and FS.

Methods
We retrospectively measured cytokine level in residual serum samples at multiple timepoints in seven children whose final diagnoses were AE or FS.

Results
The levels of 13 cytokines appeared to increase immediately after onset and peaked within 12–24 h after onset: interleukin (IL)-1β, IL-4 IL-5, IL-6, IL-8, IL-10, IL-17, eotaxin, fibroblast growth factor, granulocyte colony-stimulating factor, interferon gamma, interferon-inducible protein-10, and macrophage chemoattractant protein-1. There were no dynamic changes in the levels of three cytokines (IL-1 receptor agonist, macrophage inflammatory protein-1α, and platelet-derived growth factor-bb) 72 h after onset. Levels of some cytokines decreased to around control levels within 48 h after onset: IL-1β, IL-4, IL-5, IL-17, fibroblast growth factor, and interferon gamma. The levels of most cytokines appeared to be higher in AE, especially in hemorrhagic shock encephalopathy syndrome, than in FS.

Conclusions
Cytokine levels in both AE and FS change dynamically, such as the levels of several cytokines increased within a few hours after onset and decreased at 12–24 h after onset. Therefore, it will be desirable to make clinical decisions regarding the administration of anti-inflammatory therapy in 24 h after onset in AE.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1. Tomioka K, Nagase H, Tanaka T, Nishiyama M, Yamaguchi H, Ishida Y, et al. Early risk factors for mortality in children with seizure and/or impaired consciousness accompanied by fever without known etiology. Brain and Development. 2018;40:552–7. https://doi.org/10.1016/j.braindev.2018.02. 015.

2. Mizuguchi M, Ichiyama T, Imataka G, Okumura A, Goto T, Sakuma H, et al. Guidelines for the diagnosis and treatment of acute encephalopathy in childhood. Brain and Development. 2021;43:2–31. https://doi.org/10. 1016/j.braindev.2020.08.001.

3. Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with infuenza and other viral infections. Acta Neurol Scand. 2007;115:45–56. https://doi.org/10.1111/j.1600-0404.2007.00809.x.

4. Kasai M, Shibata A, Hoshino A, Maegaki Y, Yamanouchi H, Takanashi JI, et al. Epidemiological changes of acute encephalopathy in Japan based on national surveillance for 2014-2017. Brain and Development. 2020;42:508–14. https://doi.org/10.1016/j.braindev.2020.04.006.

5. Tomioka K, Nishiyama M, Nagase H, Ishida Y, Tanaka T, Tokumoto S, et al. Detailed clinical course of fatal acute encephalopathy in children. Brain and Development. 2019;41:691–8. https://doi.org/10.1016/j.braindev. 2019.04.012.

6. Nishiyama M, Tanaka T, Fujita K, Maruyama A, Nagase H. Targeted temperature management of acute encephalopathy without AST elevation. Brain and Development. 2015;37:328–33. https://doi.org/10.1016/j.brain dev.2014.06.005.

7. Kawano G, Iwata O, Iwata S, Kawano K, Obu K, Kuki I, et al. Determinants of outcomes following acute child encephalopathy and encephalitis: pivotal efect of early and delayed cooling. Arch Dis Child. 2011;96:936–41. https://doi.org/10.1136/adc.2009.180554.

8. Morita H, Hosoya M, Kato A, Kawasaki Y, Suzuki H. Laboratory characteristics of acute encephalopathy with multiple organ dysfunctions. Brain and Development. 2005;27:477–82. https://doi.org/10.1016/j.braindev.2004. 11.007.

9. Ichiyama T, Ito Y, Kubota M, Yamazaki T, Nakamura K, Furukawa S. Serum and cerebrospinal fuid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain and Development. 2009;31:731–8. https://doi.org/10.1016/j.braindev.2008.11.005.

10. Hosoya M, Kawasaki Y, Katayose M, Sakuma H, Watanabe M, Igarashi E, et al. Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure. Arch Dis Child. 2006;91:469–72. https://doi.org/10.1136/adc. 2005.078436.

11. Hu MH, Huang GS, Wu CT, Lin JJ, Hsia SH, Wang HS, et al. Analysis of plasma multiplex cytokines for children with febrile seizures and severe acute encephalitis. J Child Neurol. 2014;29:182–6. https://doi.org/10. 1177/0883073813488829.

12. Patterson KP, Brennan GP, Curran M, Kinney-Lang E, Dubé C, Rashid F, et al. Rapid, coordinate infammatory responses after experimental febrile status epilepticus: Implications for epileptogenesis. eNeuro. 2015;2:0034–15. https://doi.org/10.1523/ENEURO.0034-15.2015.

13. Bartfai T, Sanchez-Alavez M, Andell-Jonsson S, Schultzberg M, Vezzani A, Danielsson E, et al. Interleukin-1 system in CNS stress: Seizures, fever, and neurotrauma. Ann N Y Acad Sci. 2007;1113:173–7. https://doi.org/10. 1196/annals.1391.022.

14. Kawamura Y, Nakai H, Sugata K, Asano Y, Yoshikawa T. Serum biomarker kinetics with three diferent courses of HHV-6B encephalitis. Brain and Development. 2013;35:590–5. https://doi.org/10.1016/j.braindev.2012.08. 005.

15. Kawamura Y, Yamazaki Y, Ohashi M, Ihira M, Yoshikawa T. Cytokine and chemokine responses in the blood and cerebrospinal fuid of patients with human herpesvirus 6B-associated acute encephalopathy with biphasic seizures and late reduced difusion. J Med Virol. 2014;86:512–8. https://doi.org/10.1002/jmv.23788.

16. Ichiyama T, Suenaga N, Kajimoto M, Tohyama J, Isumi H, Kubota M, et al. Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain and Development. 2008;30:47–52. https://doi.org/10.1016/j.braindev.2007.05.008.

17. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi. org/10.1038/bmt.2012.244.

18. Nagase H, Nakagawa T, Aoki K, Fujita K, Saji Y, Maruyama A, et al. Therapeutic indicators of acute encephalopathy in patients with complex febrile seizures. Pediatr Int. 2013;55:310–4. https://doi.org/10.1111/ped. 12046.

19. Subcommittee on Febrile Seizures; American Academy of Pediatrics. Febrile seizures: guideline for the Neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics. 2011;127:389–94. https://doi.org/ 10.1542/peds.2010-3318.

20. Ogino M, Kashiwagi M, Tanabe T, Oba C, Nomura S, Shimakawa S, et al. Clinical fndings in patients with febrile seizure after 5 years of age: a retrospective study. Brain and Development. 2020;42:449–56. https://doi. org/10.1016/j.braindev.2020.02.009.

21. Fiser DH. Assessing the outcome of pediatric intensive care. J Pediatr. 1992;121:68–74. https://doi.org/10.1016/s0022-3476(05)82544-2.

22. Takanashi J, Oba H, Barkovich AJ, Tada H, Tanabe Y, Yamanouchi H, et al. Difusion MRI abnormalities after prolonged febrile seizures with encephalopathy. Neurology. 2006;66:1304–9; discussion 1291. https://doi. org/10.1212/01.wnl.0000210487.36667.a5.

23. Bacon CJ, Hall SM. Haemorrhagic shock encephalopathy syndrome in the British Isles. Arch Dis Child. 1992;67:985–93. https://doi.org/10.1136/adc. 67.8.985.

24. Kim K, Kwak BO, Kwon A, Ha J, Kim S, Bae SW, et al. Analysis of plasma multiplex cytokines and increased level of IL-10 and IL-1RA cytokines in febrile seizures. J Neuroinfammation. 2017;14:200. https://doi.org/10. 1186/s12974-017-0974-7.

25. Virta M, Hurme M, Helminen M. Increased plasma levels of pro- and anti-infammatory cytokines in patients with febrile seizures. Epilepsia. 2002;43:920–3. https://doi.org/10.1046/j.1528-1157.2002.02002.x.

26. Gallentine WB, Shinnar S, Hesdorfer DC, Epstein L, Nordli DR Jr, Lewis DV, et al. Plasma cytokines associated with febrile status epilepticus in children: a potential biomarker for acute hippocampal injury. Epilepsia. 2017;58:1102–11. https://doi.org/10.1111/epi.13750.

27. Pensato U, Muccioli L, Cani I, Janigro D, Zinzani PL, Guarino M, et al. Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann Clin Transl Neurol. 2021;8:968–79. https://doi.org/ 10.1002/acn3.51348.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る